nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Additional Neurology Topics"

 

Mild Traumatic Brain Injury and Aggression, Impulsivity, and History of Other- and Self-Directed Aggression
March 30, 2018   

Mild traumatic brain injury (mTBI) is highly prevalent in the United States, with an estimated 1.3 million reported annually. One of the major consequences of mTBI...
 Continue reading (Members only)
Autism Awareness: Review of Pharmacotherapy for Emotional/Behavioral Symptoms and Potential Future Targets
March 20, 2018   

Autism spectrum disorder (ASD) is a neurodevelopmental disorder typically diagnosed in childhood and characterized by persistent deficits in social communication and interaction and restricted, repetitive patterns of behavior, interests, and activities. There are no pharmacological agents approved...
 Continue reading
Heart Function May Correlate With Brain Function
November 24, 2017   

Studies have shown that poor cardiac health is associated with a significant increase in the risk for cognitive decline and dementia....
 Continue reading (Members only)
Ex-NFL Player Confirmed as First Case of Chronic Traumatic Encephalopathy in Living Patient
November 17, 2017   

New research appears to confirm that positron emission tomography (PET) imaging tracer can identify the distinctive brain tau pathology of chronic traumatic encephalopathy (CTE) in a living person....
 Continue reading (Members only)
Antipsychotic Use in Intellectually Disabled Adults
September 1, 2017   

Antipsychotic medication is frequently being prescribed to individuals with intellectual and developmental disabilities (IDD), often without a psychiatric diagnosis...
 Continue reading
Deutetrabenazine Approved to Treat Tardive Dyskinesia
August 30, 2017   

The U.S. Food and Drug Administration (FDA) has approved deutetrabenazine, trade name Austedo, for the treatment of tardive dyskinesia...
 Continue reading
What's New in Tardive Dyskinesia?
June 30, 2017   

Tardive dyskinesia was the focus of several sessions, lectures, and posters at the recent 2017 American Psychiatric Association (APA) Annual Meeting...
 Continue reading (Members only)
Antidepressants and Risk for Autism, ADHD
May 12, 2017   

Recently published studies suggests that mothers' use of antidepressants during early pregnancy does not increase the risk of their children developing autism or attention deficit hyperactivity disorder, conditions previously associated with these medications....
 Continue reading (Members only)
First Drug Approved to Treat Tardive Dyskinesia
April 12, 2017   

The U.S. Food and Drug Administration (FDA) has approved valbenazine, trade name Ingrezza, for the treatment of tardive dyskinesia...
 Continue reading
Concussion in Children: New Data
January 11, 2017   

New studies address the association between early exercise following acute concussion and persistent postconcussive symptoms in children and adolescents as well as auditory biological markers of concussion in children.
 Continue reading (Members only)
123
Top of Page